Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation

Por Limdi, Nita A.
Publicado em 2012

Reversal of Oral Anticoagulation

Por Thigpen, Jonathan L., Limdi, Nita A.
Publicado em 2013

Pharmacogenetics of warfarin dosing in patients of African and European ancestry

Por Shendre, Aditi, Dillon, Chrisly, Limdi, Nita A
Publicado no Pharmacogenomics (2018)

High-dimensional pharmacogenetic prediction of a continuous trait using machine learning techniques with application to warfarin dose prediction in African Americans

Por Cosgun, Erdal, Limdi, Nita A., Duarte, Christine W.
Publicado em 2011

Vitamin K intake, body mass index and warfarin maintenance dose

Por Kabagambe, Edmond K, Beasley, Timothy M., Limdi, Nita A.
Publicado em 2013

Validation of the Spartan RXCYP2C19 Genotyping Assay Utilizing Blood Samples

Por Davis, Brittney H., DeFrank, Gina, Limdi, Nita A., Harada, Shuko
Publicado no Clin Transl Sci (2019)

Controlling Population Structure in Human Genetic Association Studies with Samples of Unrelated Individuals

Por LIU, NIANJUN, ZHAO, HONGYU, PATKI, AMIT, LIMDI, NITA A., ALLISON, DAVID B.
Publicado em 2011

Influence of age on warfarin dose, anticoagulation control, and risk of hemorrhage

Por Shendre, Aditi, Parmar, Gaurav M., Dillon, Chrisly, Beasley, T. Mark, Limdi, Nita A.
Publicado no Pharmacotherapy (2018)

INFLUENCE OF KIDNEY FUNCTION ON RISK OF HEMORRHAGE AMONG PATIENTS TAKING WARFARIN: A COHORT STUDY

Por Limdi, Mohit A., Crowley, Michael R, Beasley, T Mark, Limdi, Nita A., Allon, Michael
Publicado em 2012

US mortality: Influence of race, geography and cardiovascular risk among participants in the population-based REGARDS cohort

Por Limdi, Nita A., Howard, Virginia J., Higginbotham, John, Parton, Jason, Safford, Monika M., Howard, George
Publicado no J Racial Ethn Health Disparities (2015)

Quality of anticoagulation control and hemorrhage risk among African American and European American warfarin users

Por Limdi, Nita A., Brown, Todd M., Shendre, Aditi, Liu, Nianjun, Hill, Charles E., Beasley, T. Mark
Publicado no Pharmacogenet Genomics (2017)

Influence of Regular Physical Activity on Warfarin Dose and Risk of Hemorrhagic Complications: Physical Activity and Warfarin Response

Por Shendre, Aditi, Beasley, T. Mark, Brown, Todd M., Hill, Charles E., Arnett, Donna K., Limdi, Nita A.
Publicado em 2014

A systematic analysis and comparison of warfarin initiation strategies

Por French, Benjamin, Wang, Le, Gage, Brian F., Horenstein, Richard B., Limdi, Nita A., Kimmel, Stephen E.
Publicado no Pharmacogenet Genomics (2016)

Local Ancestry and Clinical Cardiovascular Events Among African Americans From the Atherosclerosis Risk in Communities Study

Por Shendre, Aditi, Irvin, Marguerite R., Wiener, Howard, Zhi, Degui, Limdi, Nita A., Overton, Edgar T., Shrestha, Sadeep
Publicado no J Am Heart Assoc (2017)

Race‐based and sex‐based differences in bioactive lipid mediators after myocardial infarction

Por Halade, Ganesh V., Kain, Vasundhara, Dillion, Chrisly, Beasley, Mark, Dudenbostel, Tanja, Oparil, Suzanne, Limdi, Nita A.
Publicado no ESC Heart Fail (2020)

Effect of Left Ventricular Systolic Dysfunction on Response to Warfarin

Por Ather, Sameer, Shendre, Aditi, Beasley, T. Mark, Brown, Todd, Hill, Charles E., Prabhu, Sumanth D., Limdi, Nita A.
Publicado no Am J Cardiol (2016)

Influence of Kidney Transplant Status on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage

Por Yanik, Megan V., Irvin, Marguerite R., Beasley, T. Mark, Jacobson, Pamala A., Julian, Bruce A., Limdi, Nita A.
Publicado no Pharmacotherapy (2017)

Between a rock and a hard place: a high-risk patient with resistance to multiple P2Y(12) antagonists

Por Davis, Brittney H, Dillon, Chrisly, Cai, Anping, Williams III, Lance A, Pamboukian, Salpy V, Limdi, Nita A
Publicado no Pharmacogenomics (2019)

Race-specific influence of CYP4F2 on dose and risk of hemorrhage among warfarin users

Por Shendre, Aditi, Brown, Todd M., Liu, Nianjun, Hill, Charles E, Beasley, T. Mark, Nickerson, Deborah. A., Limdi, Nita. A.
Publicado no Pharmacotherapy (2016)

Genetic Deletion of 12/15 Lipoxygenase Promotes Effective Resolution of Inflammation Following Myocardial Infarction

Por Kain, Vasundhara, Ingle, Kevin A., Kabarowski, Janusz, Barnes, Stephen, Limdi, Nita A., Prabhu, Sumanth D., Halade, Ganesh V.
Publicado no J Mol Cell Cardiol (2018)